326 р (7 таблеток). Average price online * 326 r (7 tablets).
Where can one buy:
Instructions for use
As a result of taking Xisal, H1 and H2-histamine receptors are blocked, as a result of which the allergic reaction is stopped very quickly and possible bronchospasm is prevented.
It is recommended to take Ksizal with the following diseases and conditions:
- Rhinitis and conjunctivitis of an allergic nature, which occur seasonally or bother the patient throughout the year;
- allergic reaction to pollen of flowering plants ;
- skin allergies;
- bronchospasms caused by swelling of the mucous membrane of the respiratory tract as a result of contact with the allergen, including angioedema ;
- cough allergic etiology.
Dosage and administration
In the pharmacy chain, you can find Ksizal in the form:
- 5 mg tablets, packaged in blisters of 7 and 10 pieces;
- drops - a colorless solution in vials of 10 or 20 ml.
Regardless of the dosage form, Xyzal is ingested with a small amount of water, on an empty stomach or during meals.
|Category of patients||Recommended dosage and frequency of administration|
|Children from 2 to 6 years||can not take||5 drops twice a day|
|Children from 6 to 12 years||half a pill twice a day||10 drops twice a day|
|Children from 12 years old and adults||1 tablet per day||20 drops daily|
|Patients with renal failure||1 tablet every 2-3 days||7-10 drops daily|
The course of treatment is on average from 1 to 6 weeks. If necessary, Xyzal can be taken continuously for 1-1.5 years.
To absolute contraindications to receive Kzizala include:
- children's age (up to 2 years - for drops, up to 6 years - for tablets);
- pregnancy and lactation;
- hypersensitivity to the active or auxiliary substances in the composition of the drug (in particular, lactase deficiency, allergy to piperazine or levocetirizine);
- severe renal failure.
With caution it is necessary to take Ksizal for people with kidney diseases and elderly patients, in whom the function of the urinary system can be impaired due to age-related changes.
Less than 10% of consumers of this medication have such undesirable side effects:
- dry mouth.
Less than 1% of consumers recorded such side effects:
- weight gain;
- abdominal pain.
It is extremely rare (in 1 out of 5–10 thousand patients) Xyzal leads to the development of serious pathologies on the part of the respiratory and nervous systems, such as:
- respiratory disorders;
- psychomotor agitation.
|Components||The composition of the tablets Xizal||The composition of drops of Xyzal|
|Active substance||levocyterisin hydrochloride||levocetirizine hydrochloride|
The drug is rapidly absorbed from the digestive tract and begins to act almost instantly. Xyzal reaches its maximum concentration in the blood in about an hour, the pronounced therapeutic effect lasts another day.
The drug is removed from the body gradually, over several days, mainly by the kidneys. When ingested, the liver does not form any pharmacologically active compounds, which determines its safety and the absence of drug interaction with other pharmaceutical agents.
Simultaneous use of Xyzal and theophylline can lead to a slight deterioration in the absorption of levocetirizine in the gastrointestinal tract.
It is not recommended to combine the administration of Kzizal and alcohol in any doses, since this can provoke various nervous disorders from depression to over-stimulation of the nervous system.
Accidental overdose of Xyzalom is virtually impossible. Symptoms may include apathy, drowsiness, and CNS depression. In the case of simultaneous taking of an unnecessarily large dose of this drug, you must take any adsorbing agent or flush the stomach, and seek the help of a qualified technician.
It is released without a prescription (formally, today pills are released without a prescription, drops by prescription).
In the dark place at a temperature of no higher than 30 ° C.
Expiration date for tablets and for drops - 3 years. After opening the bottle, the shelf life of drops is 3 months.
(Leave your feedback in the comments)
* - The average value among several sellers at the time of monitoring is not a public offer.